NCT00467506View on ClinicalTrials.gov

Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Thyroid Neoplasms
Interventions
DRUG

bispecific antibody and di-DTPA-131I

Trial Locations (11)

13385

Hôpital de la timone, Marseille

14076

Centre François Baclesse, Caen

31052

Centre Claudius Régaud, Toulouse

38043

CHU de Grenoble, Grenoble

44093

CHU, Nantes

67065

Centre Paul Strauss, Strasbourg

69394

CHU, Lyon

76230

CHU, Rouen

87042

hôpital du Cluzeau, Limoges

92210

Centre René Huguenin, Saint-Cloud

440805

Centre René Gauducheau, Saint-Herblain

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT00467506 - Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma | Biotech Hunter | Biotech Hunter